via University of Wisconsin–Madison
Like the hardiest weed, glioblastoma almost always springs back — usually within months after a patient’s initial brain tumor is surgically removed. That is why survival rates for this cancer are just 25 percent at one year and plummet to 5 percent by the five-year mark.
One of the challenges of treating this disease is that surgeons can’t always remove every bit of tumor or glioma stem cells that might linger in the brain.
“One characteristic of glioblastoma is that the tumor cells are very aggressive, and they will infiltrate the surrounding tissues. So the surgeon can’t clearly feel the boundaries between the tumor and the normal tissue, and you cannot remove as much as possible because all the tissues in the brain are extremely important — you certainly don’t want to remove too much,” explains Quanyin Hu, an assistant professor in the University of Wisconsin–Madison School of Pharmacy’s Pharmaceutical Sciences Division. “So the tumor will come back again, and that sharply decreases the survival rate after treatment.”
But Hu’s Cell-Inspired Personalized Therapeutic (CIPT) Lab has developed a powerful immunity-boosting postoperative treatment that could transform the odds for patients with glioblastoma. Hu and his collaborators published their research on the treatment’s use in mouse models of human glioblastoma this month in the journal Science Translational Medicine.
“It provides hope for preventing glioblastoma relapse,” Hu says. “We prove that it can actually eradicate these glioma stem cells, which can eventually prevent the glioblastoma from coming back. We can significantly improve survival.”
Hu’s lab developed a hydrogel that can be injected into the brain cavity left behind by the excised tumor. The hydrogel delivery method works well because it completely fills the brain cavity, slowly releases the medicine into the surrounding tissue, and promotes the cancer-killing immune response, Hu notes.
“We have a lot of work to do before it can be potentially translated into the clinic, but we feel confident that this is a very promising approach for bringing new hope to patients with glioblastoma so they can recover after surgery.”
Quanyin Hu
The hydrogel is packed with nanoparticles designed to enter and reprogram certain types of immune cells called macrophages. These immune cells normally clean up infectious invaders in the body, but in the tumor environment, they can change into a form that instead suppresses the immune system and promotes cancer growth. And because of the inflammation created by surgery, these rogue macrophages flock to the surgical site, potentially fueling cancer relapse.
“We want to take advantage of these macrophages and turn them from enemy to ally,” Hu says.
To do that, the nanoparticles can engineer the macrophages to target a glycoprotein called CD133, a marker for cancer stem cells. Hu’s team also added an antibody, CD47, that blocks a “don’t-eat-me” signal to promote macrophages to recognize the cancer cells. The preclinical results in mice models show that the hydrogel treatment successfully generated glioma stem cell-specific chimeric antigen receptor (CAR) macrophages — essentially engineering the immune cells on site to target and kill any lingering glioma stem cells.
If effective in humans, the hydrogel treatment could eliminate the need for postsurgical chemotherapy or radiation, reducing toxic side effects while also improving patient outcomes.
Hu’s next step is testing the hydrogel in larger animal models and also monitoring long-term efficacy and toxicity beyond the four- to six-month period he previously studied.
“We have a lot of work to do before it can be potentially translated into the clinic, but we feel confident that this is a very promising approach for bringing new hope to patients with glioblastoma so they can recover after surgery,” Hu says. “We hope we can do our work to be able to advance this technology to the clinic.”
While Hu’s team is initially focused on glioblastoma, the treatment approach could also be applied to other aggressive solid tumors, including breast cancer, he notes. “Our approach is taking advantage of the macrophages in the postsurgical areas and to locally engineer these macrophages,” he says. “In this scenario, we can confidently say that it will apply to the majority of solid tumors with high invasive characteristics.”
Original Article: New injectable gel offers promise for tough-to-treat brain tumors
More from: University of Wisconsin-Madison
The Latest Updates from Bing News
Go deeper with Bing News on:
Immunity-boosting postoperative treatment
- Bestqool proves the effectiveness and safety of its red light therapy device with a professional third-party Report
Bestqool, a well-reputed manufacturer of red light therapy devices with a vision of helping people achieve a healthier lifestyle, has proudly announced the results of a comprehensive third-party ...
- What exactly is lymphatic drainage massage?
But manual lymphatic drainage is nothing new. This specific type of massage has long been employed to enhance the function of the lymphatic system – a large network of tissues and organs that help rid ...
Go deeper with Bing News on:
Hydrogel delivery method
- Vietnam Advanced Drug Delivery Market Onward and Upward Market Size’s Path to New Heights
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Market offers comprehensive insights into the market landscape, customer intelligence, and ...
- Innovative peptide-based hydrogel therapy for virus prevention
Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop.
- Technion breakthrough for better drug delivery and tissue implantation
Researchers develop ultrasound for non-invasive method for bio-printing live cells and tissues deep within the body.
- Mechanical engineers develop miniaturized, hydrogel-based electric generators for biomedical devices
Mechanoelectrical energy conversion offers a promising solution for powering miniaturized biomedical devices, such as cardiac pacemakers, brain stimulators, wearable drug delivery systems, and more.
- The Role of Piezoelectric Materials in Medical Devices
Piezoelectric materials are used in various medical devices, including ultrasound imaging devices, drug delivery systems ... 7 In a 2019 study, researchers proposed a novel method to enhance the ...